Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study

In the PLATelet inhibition and patient Outcomes (PLATO) study of patients with acute coronary syndromes, ticagrelor reduced mortality compared to clopidogrel but the mechanisms for this mortality reduction remain uncertain. We analysed adverse events (AEs) consistent with either pulmonary infection...

Descripción completa

Detalles Bibliográficos
Autores principales: Storey, Robert F., James, Stefan K., Siegbahn, Agneta, Varenhorst, Christoph, Held, Claes, Ycas, Joseph, Husted, Steen E., Cannon, Christopher P., Becker, Richard C., Steg, Ph Gabriel, Åsenblad, Nils, Wallentin, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Informa UK Ltd. 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220996/
https://www.ncbi.nlm.nih.gov/pubmed/24127651
http://dx.doi.org/10.3109/09537104.2013.842965

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220996/
https://www.ncbi.nlm.nih.gov/pubmed/24127651
http://dx.doi.org/10.3109/09537104.2013.842965

Ejemplares similares